Search Results for: cryo-cell

Cryo Cell reviews: dubious cord cell clinic plans, risks, other issues

Cryo Cell, Cryo-Cell

In today’s post I review the cord blood firm Cryo Cell International and discuss specific concerns I have about it. A major issue is their plan to open a clinic selling unproven cord cell infusions to kids. I believe this is risky both for the firm and more importantly for the children. What is Cryo …

Cryo Cell reviews: dubious cord cell clinic plans, risks, other issues Read More »

16 predictions for stem cells & regenerative medicine in 2022

regenerative medicine, stem cells 2021

The last few years in the stem cell and regenerative medicine arena have been complicated in many ways. Variables like surging stem cell clinics and COVID have made predictions harder.  Even so, trying to make predictions is useful and it’s fun to go over past year’s predictions. You can see my scorecard on my 2021 …

16 predictions for stem cells & regenerative medicine in 2022 Read More »

Top stem cell stories of 2021: COVID, diabetes, human embryos, clinics in court

regenerative medicine, stem cells 2021

The past year was all over the place for the stem cell and regenerative medicine field. As you can see in my scoring of my 21 predictions for 2021, quite a few things were surprises in terms of what did and didn’t happen. Here’s an overview of the top stories of the year in our …

Top stem cell stories of 2021: COVID, diabetes, human embryos, clinics in court Read More »

2021 scorecard for stem cell stocks: REGN, VCEL, CCEL, LCTX did best

Mesoblast stock

A quick review of the publicly-traded stem cell stocks I’ve been following in 2021 finds mostly discouraging news, but a few firms relatively outperformed the other publically-traded biotechs. One had some great news today. In this post, I’m doing a brief overview of how things went this year in the regenerative medicine space. I’m going …

2021 scorecard for stem cell stocks: REGN, VCEL, CCEL, LCTX did best Read More »

Weekly reads: New FDA guidance, brains, MSCs, senescence

human mouse marmoset brain

This week marked the release of new draft FDA guidance on cell and gene therapies. Is the FDA kind of like the guidance counselor at school or more like the principal? It probably depends on many factors. I also find it funny how pretty much everyone in academia and biotech industry works to be compliant …

Weekly reads: New FDA guidance, brains, MSCs, senescence Read More »

Fact-checking stem cell therapy for autism: still a risky idea

Duke-Curemark-autism-study-pamphlet

The other day I gave a talk in part about stem cell hype and mentioned as an example how the idea of already doing stem cell therapy for autism seems so misguided to me now.  On the whole, in my view there are major downsides and risks for autistic kids whose parents are already having …

Fact-checking stem cell therapy for autism: still a risky idea Read More »

Cord conflicts at the journal Stem Cells Translational Medicine

Cord-blood-autism, Cryo Cell

The journal Stem Cells Translational Medicine has a long track record of publishing great work. I also have a lot of respect for the editors there and I’ve published there myself. But a few recent events have sparked concerns including over possible undisclosed conflicts of interest in some papers there about cord blood for autism. …

Cord conflicts at the journal Stem Cells Translational Medicine Read More »

24 cell therapy & stem cell stocks I’m following

stem cell stocks

Stem cell stocks, meaning cellular therapy biotech companies, face many challenges, but their clinical research is crucial. Stem cell biotechs These biotechs have ups and downs, sometimes at the same time. This is kind of the standard of “life” as any biotech company. It is definitely the case in the volatile stem cell and cell …

24 cell therapy & stem cell stocks I’m following Read More »